“My ambition is to develop new formulations and manufacturing processes to reduce side effects and increase bioavailability. To promote health and well-being across diverse populations worldwide.”

Dr Aslihan Arslan is an Award-winning Pharmaceutical Technologist, responsible for managing and leading the development of formulations, manufacturing processes, scale-up and technology transfer studies. Dr Arslan completed her Ph.D in Pharmaceutical Technology, writing a thesis on innovative scientific procedures for increasing the solubility and bioavailability of pharmaceutical compounds and substances using quality-by-design. In her role as Scientific Advisor at B・SYNC ON parent company, Galventa, Dr Arslan is responsible for the development and manufacturing of B・SYNC ON. Outside of her work, Dr Arslan is a devotee of the outdoors with a passion for everything under the sky, including nature, trekking, cross-country skiing, snowboarding and roller skating. She also enjoys photography.

“Whether it's cryptocurrencies, quantum computing or a new sport…I'm passionate to learn and drive new endeavors.”

Sascha Fritsche worked for major banking institutions and consulting companies including Credit Suisse, Nomura and Helbling Management Consulting before embarking upon a career as an entrepreneur. As CFO in his first start-up, he was responsible for the corporate set-up, the design of the transfer pricing rules as well as conducting financial and legal due diligence during several investment rounds and minority acquisitions. As a serial entrepreneur, Sascha is responsible for its growth, strategy and finance. He says of his career, “I'm passionate about bringing new ideas and initiatives to life. Whether it's about a new trend such as cryptocurrencies or quantum computing or whether it is about a new sport I'm trying out for the first time. This drives me to push my boundaries in every new project or initiative I embrace.”

„Meine früheren Chefs nannten mich „Trüffelschwein“, weil ich geschickt darin bin, wissenschaftliche Technologien aufzuspüren und sie in ethische Geschäfte umzuwandeln.“

Michael has studied chemistry and biology with a Ph.D. from ETH Zurich. He has significant experience from previous R&D roles at leading industrial Life Science organizations in metabolic and cardiovascular health. A serial entrepreneur, Michael has led several start-up companies to profitability, including Siegfried Biologics, Kuros Biosciences and ChromaCon. Besides his assignment with Galventa, Michael is engaged in helping a Venture boutique company, Remora Capital to launch new start-up companies in the field of Cancer/Immunology and Healthy Aging. Having a specific interest in nutraceuticals and healthy aging, Michael works on developing new products, focusing on manufacturing, regulatory and quality issues. Michael supports organizations for disabled children and likes to meet his friends and extended family members to celebrate occasions as they occur. Michael enjoys studying art and history of late antiquity and is fond of classical music.

"I am fascinated by the impact and influence of nutritional substances on the body and mind."

Michael holds a Master of Science in Molecular Health Science and a PhD in Neuroscience from the ETH Zurich. He specializes in the impact of nutrition and pharmacological substances on health and prevention of chronic diseases and is passionate about the ongoing research and new insights in the supplement industry. During his doctorate, Michael has investigated the clinical potential of new substances for treating psychological disorders, such as depression and anxiety. In his role as Product Development Lead at the B·SYNC parent company, Galventa, Michael is responsible for developing new products based on the latest scientific data. Michael is passionate about living a healthy lifestyle and has been a biohacker for many years, following scientific insight that small, incremental changes to his diet and supplementation can enhance his overall health and performance. “I have always dreamed of working within the supplement industry and I am enjoying applying the knowledge and insight gained from my Masters and PHD studies to creating new products at Galventa, and to being part of an exciting start-up initiative.” Outside of work, Michael enjoys meeting his friends, and going to the gym.

Idil arbeitet gerne persönlich mit Verbrauchern und Partnern zusammen, um die Wirkung der Zusammenarbeit zu maximieren.

Idil holds a Bachelor of BA from METU, Turkey. She previously worked as a field marketing team leader at Red Bull, where she helped to create and deliver a regional marketing plan in line with the national strategy to drive product trials and brand awareness. She is currently working as a business development and marketing specialist for our B2B partners, where she is responsible for market analysis, identifying target audiences and developing digital marketing strategies accordingly.board of promising USZ-start-ups.

„Die Entwicklung von Rezepturen, Herstellungsverfahren und neuen Technologien ist meine Leidenschaft.“

Dr Fırat Yerlikaya has previously founded Elixir Pharmaceutical Research and Development Corporation in Ankara, Turkey where he had been working as the Managing Director until he joined Galventa. He comes with a Master's and Doctorate Degrees in Pharmaceutical Technology and previous tenures in Washington DC, where he was invited to the US FDA as an ORISE fellow. Fırat continues his scientific studies with the development of complex pharmaceutical formulations and processes using quality-by-design and chemometric models. At B・SYNC ON parent company, Galventa, Fırat is responsible for supporting the development of formulations, manufacturing processes, scale-up and technology transfer studies, as well as providing analytical methodology and insights. Outside of his academic studies and work, Fırat is a passionate sailor, and enjoys sailing in the seas where Galenos used to live. He also enjoys fine whiskey and good food with his family and friends.

I'm passionate about the intricate interplay between the brain and the mind and how chemical substances can dramatically change the way we perceive the outer and inner world.

Dario Dornbierer is a pharmaceutical scientist (ETH Zurich), Swiss Federal pharmacist and clinical psychopharmacologist who specializes in drug development in mental health. After a residency year in a Swiss pharmacy, Dario conducted a PhD in the field of clinical psychopharmacology at the Psychiatric University Hospital in Zurich, where he investigated the antidepressant potential of several drug candidates, applying state-of-the-art neuroscientific methods (EEG , MRI, etc.). With a special focus on sleep pharmacology, he investigated the ability of several compounds to promote deep sleep and improve overall sleeping and waking functions. In his role as CSO, Dario is responsible for all aspects related to clinical sciences and innovation. Dario is passionate about the intricate interplay between the brain and the mind and how chemical substances can dramatically change the way we perceive the outer and inner world. As a pharmacist, I find it exciting to apply cutting-edge technologies to improve the safety, tolerability and efficacy of products. Dario is passionate about spending time with his wife and two kids, gardening and playing various instruments.

Ich stehe für die Förderung sinnvollen Wachstums durch innovative, datengesteuerte Strategien, die messbare Auswirkungen erzielen. Ich glaube an ständiges Experimentieren, Lernen und Optimieren der Customer Journey.

Gabriel holds a bachelor's degree in International Business from the University of Westminster, London. During the last years he gained extensive experience as a Digital Strategy Manager at Education First where he was responsible for all paid digital marketing initiatives in North America, Nordics, and Eastern Europe. In his role Gabriel leads growth through in our D2C channels including Google, TikTok, Meta, Snapchat etc.

Basti ist gespannt, wie die digitale Entwicklung die Zukunft beeinflussen wird

Bastian ist begeistert von der digitalen Landschaft und liebt es, verschiedene Dinge auszuprobieren, Konzepte zu studieren und diese in Aktion zu sehen. Er ist begeistert davon, wie die digitale Entwicklung die Zukunft beeinflussen wird und wie wir mit den vielversprechendsten Tools der Zukunft eine weltweite Marke aufbauen können. Er hat sich umfassende Kenntnisse über die Einführung globaler Verbrauchermarken und globaler digitaler Strategien angeeignet. In seiner letzten Rolle als Digital Marketing Manager bei Smood leitete er alle Facetten des nationalen Marketings und sorgte für ein dreistelliges Wachstum von Jahr zu Jahr.